Does Acarbose Slow Carbohydrate Digestion?
Yes, acarbose directly and effectively slows the digestion of carbohydrates through competitive, reversible inhibition of key digestive enzymes in the small intestine. 1
Mechanism of Action
Acarbose works by inhibiting two critical enzyme systems 1:
- Pancreatic alpha-amylase: Blocks the breakdown of complex starches into oligosaccharides in the small intestine lumen
- Membrane-bound intestinal alpha-glucosidases: Prevents the conversion of oligosaccharides, trisaccharides, and disaccharides into glucose and other monosaccharides at the intestinal brush border
This dual inhibition creates a cascade effect that delays carbohydrate absorption, resulting in smaller postprandial glucose rises 1, 2. The drug acts locally within the gastrointestinal tract, which is why less than 2% is absorbed systemically as active drug 1.
Clinical Impact
The delayed carbohydrate digestion produces several therapeutic effects:
- Reduced postprandial hyperglycemia: By slowing carbohydrate breakdown, glucose enters the bloodstream more gradually 3, 2
- Lower glycosylated hemoglobin: Sustained reduction in blood glucose peaks translates to improved HbA1c levels 1
- No insulin secretion enhancement: Unlike sulfonylureas, acarbose doesn't stimulate pancreatic insulin release—its effect is purely digestive 1
Additional Mechanisms
Beyond enzyme inhibition, acarbose may also slow gastric emptying 4. When healthy subjects received sucrose with acarbose, there was significant delay in gastric emptying as measured by paracetamol absorption, with the exaggerated GLP-1 release potentially contributing to this effect 4.
Important Caveats
The slowed digestion means undigested carbohydrates reach the colon, which explains the characteristic gastrointestinal side effects 1:
- Flatulence (74% of patients in trials)
- Diarrhea (31% of patients)
- Abdominal discomfort (19% of patients)
These effects are dose-dependent and typically diminish over time 5, 1. Starting with low doses and titrating slowly while ensuring patients follow their prescribed diabetic diet minimizes these adverse effects 5.
Acarbose has no activity against lactase, so it does not cause lactose intolerance 1.
The drug is metabolized exclusively within the GI tract by intestinal bacteria and digestive enzymes, with approximately 51% excreted in feces as unabsorbed drug-related material 1. This local action is therapeutically desired and confirms the drug's primary mechanism occurs at the site of carbohydrate digestion.